Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 6 Analysis of putative sterol-responsive element (SRE) present in the NOSIII promoter by electrophoretic mobility shift assay (EMSA). (Upper) Representative EMSA was performed with a 32P end-labeled probe containing the SRE element and nuclear extracts from cells treated for 24 h with nLDL (100 µg/ml), glycLDL (100 µg/ml), oxLDL (100 µg/ml), glyc-oxLDL (30 µg/ml), glyc-oxLDL (100 µg/ml), glyc-oxLDL (300 µg/ml), glyc-oxLDL (100 µg/ml, second form), and glyc-oxLDL (100 µg/ml, second form). (Lower) The EMSA was performed with the Oct-1 element used as a control agent to normalize the results (as described in [55]) and with a nuclear extract from cells treated for 24 h with the same lipoproteins. Abbreviations as in Figure 2.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement